>
VIA Pharmaceuticals Inc logo

VIAP - VIA Pharmaceuticals Inc Share Price

$0.001 0.0  0.0%

Last Trade - 03/09/21

Sector
Healthcare
Size
Micro Cap
Market Cap £7.48k
Enterprise Value £10.1m
Revenue £n/a
Position in Universe th / 7149
Bullish
Bearish
Unlock VIAP Revenue
Momentum
Relative Strength (%)
1m +144.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -98.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2005 2006 2007 2008 2009 2010 2011E 2012E CAGR / Avg
0.083 0.000 0.000 0.000 0.000 0.000 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2010, VIAPharmaceuticals Inc revenues was not reported. Net lossdecreased 54% to $9.6M. Lower net loss reflects Research &Develop. decrease of 70% to $1.8M (expense), Interestexpense decrease of 54% to $3.6M (expense). Basic Earningsper Share excluding Extraordinary Items increased from-$1.05 to -$0.47.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VIAP Revenue Unlock VIAP Revenue

Net Income

VIAP Net Income Unlock VIAP Revenue

Normalised EPS

VIAP Normalised EPS Unlock VIAP Revenue

PE Ratio Range

VIAP PE Ratio Range Unlock VIAP Revenue

Dividend Yield Range

VIAP Dividend Yield Range Unlock VIAP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
VIAP EPS Forecasts Unlock VIAP Revenue
Profile Summary

VIA Pharmaceuticals, Inc. (VIA) is a development-stage biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. The Company’s lead compound, VIA-2291, targets an unmet medical need of reducing atherosclerotic plaque inflammation, which is an underlying cause of atherosclerosis and its complications. Atherosclerosis is a cardiovascular disease that results from chronic inflammation and the build-up of plaque in arterial blood vessel walls. The Company’s clinical development strategy integrates several technologies to provide clinical proof-of-concept, as early as possible in the clinical development process. These technologies include the measurement of biomarkers, medical imaging of the coronary and carotid vessel walls to evaluate the plaque characteristics, and atherosclerotic plaque bioassays.

Directors
Last Annual December 31st, 2010
Last Interim December 31st, 2010
Incorporated June 14, 2004
Public Since July 4, 1993
No. of Shareholders: 122
No. of Employees: 6
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 20,560,446
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
VIAP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VIAP
Upcoming Events for VIAP
Frequently Asked Questions for VIA Pharmaceuticals Inc
What is the VIA Pharmaceuticals Inc share price?

As of 03/09/21, shares in VIA Pharmaceuticals Inc are trading at $0.001, giving the company a market capitalisation of £7.48k. This share price information is delayed by 15 minutes.

How has the VIA Pharmaceuticals Inc share price performed this year?

Shares in VIA Pharmaceuticals Inc are currently trading at $0.001 and the price has moved by -87.8% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the VIA Pharmaceuticals Inc price has moved by -90.66% over the past year.

What are the analyst and broker recommendations for VIA Pharmaceuticals Inc?

There are no analysts currently covering VIA Pharmaceuticals Inc.

When will VIA Pharmaceuticals Inc next release its financial results?

VIA Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2011-12-31
What is the VIA Pharmaceuticals Inc dividend yield?

VIA Pharmaceuticals Inc does not currently pay a dividend.

Does VIA Pharmaceuticals Inc pay a dividend?

VIA Pharmaceuticals Inc does not currently pay a dividend.

When does VIA Pharmaceuticals Inc next pay dividends?

VIA Pharmaceuticals Inc does not currently pay a dividend.

How do I buy VIA Pharmaceuticals Inc shares?

To buy shares in VIA Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of VIA Pharmaceuticals Inc?

Shares in VIA Pharmaceuticals Inc are currently trading at $0.001, giving the company a market capitalisation of £7.48k.

Where are VIA Pharmaceuticals Inc shares listed? Where are VIA Pharmaceuticals Inc shares listed?

Here are the trading details for VIA Pharmaceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: VIAP
What kind of share is VIA Pharmaceuticals Inc?

We were not able to load our ranking data for VIA Pharmaceuticals Inc

Is there a VIA Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for VIA Pharmaceuticals Inc.

How can I tell whether the VIA Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VIA Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been -95.43%. At the current price of $0.001, shares in VIA Pharmaceuticals Inc are trading at -94.27% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the VIA Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for VIA Pharmaceuticals Inc.

Who are the key directors of VIA Pharmaceuticals Inc?

VIA Pharmaceuticals Inc's management team is headed by:

John Larson - IND
Frederick Craves - IND
David Howard - IND
Douglass Given - CHM
Mark Bagnall - IND
Lawrence Cohen - CEO
Rebecca Taub - SVP
Karen Wright - CFO
Who are the major shareholders of VIA Pharmaceuticals Inc?

Here are the top five shareholders of VIA Pharmaceuticals Inc based on the size of their shareholding:

Similar to VIAP
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.